This is a routine administrative filing with no trading implications. Monitor future filings for updates on the company's Phase 3 program for ATH434 in Multiple System Atrophy and any capital raise activities given the going concern disclosure in the prior 20-F.
Price Chart
Executive Summary
Alterity Therapeutics filed a Form 6-K with an exhibit (Exhibit 99.1) titled 'Notification regarding unquoted securities - ATH'. The filing is a routine administrative notification regarding unquoted securities and contains no new financial data, operational updates, or material corporate events.
Key Facts
- Filed Form 6-K on October 23, 2026
- Exhibit 99.1 is a notification regarding unquoted securities - ATH
- No financial results, guidance, or material business updates provided
- Filing incorporated by reference into existing S-8 and F-3 registration statements
Financial Impact
No financial impact; filing is a routine securities notification with no dollar amounts disclosed.
Risk Factors
- No material information disclosed; stock may continue its historical downward drift pattern
- Company faces substantial doubt about going concern per prior 20-F filing
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001437749-26-033320 |
| Document: 0001437749-26-033320-index-headers.html | 0001437749-26-033320 |
| Document: 0001437749-26-033320-index.html | 0001437749-26-033320 |
| Document: 0001437749-26-033320.txt | 0001437749-26-033320 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 23, 2026 4d ago | 6-K | $2.09 | awaiting T+60 | — | $2.06 (+1.44%) |
Oct 23, 2026 4d ago | 6-K | $2.09 | awaiting T+60 | — | $2.06 (−1.44%) |
Oct 23, 2026 4d ago | 6-K | $2.09 | awaiting T+60 | — | $2.06 (−1.44%) |
Oct 21, 2026 6d ago | 6-K | $2.39 | awaiting T+60 | — | $2.06 (−13.81%) |
Oct 21, 2026 6d ago | 6-K | $2.39 | awaiting T+60 | — | $2.06 (−13.81%) |
Oct 19, 2026 8d ago | 6-K | $2.43 | awaiting T+60 | — | $2.06 (−15.23%) |
Oct 9, 2026 18d ago | 6-K | $3.12 | awaiting T+60 | — | $2.06 (−33.97%) |
Oct 5, 2026 22d ago | Press Release | $3.22 | awaiting T+60 | — | $2.06 (−36.02%) |
Oct 5, 2026 22d ago | 6-K | $3.22 | awaiting T+60 | — | $2.06 (−36.02%) |
Sep 25, 2026 4w ago | 6-K | $3.67 | awaiting T+60 | — | $2.06 (−43.87%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers